Literature DB >> 22898768

A high-fat-diet-induced cognitive deficit in rats that is not prevented by improving insulin sensitivity with metformin.

A D McNeilly1, R Williamson, D J K Balfour, C A Stewart, C Sutherland.   

Abstract

AIMS/HYPOTHESIS: We previously demonstrated that animals fed a high-fat (HF) diet for 10 weeks developed insulin resistance and behavioural inflexibility. We hypothesised that intervention with metformin would diminish the HF-feeding-evoked cognitive deficit by improving insulin sensitivity.
METHODS: Rats were trained in an operant-based matching and non-matching to position task (MTP/NMTP). Animals received an HF (45% of kJ as lard; n = 24), standard chow (SC; n = 16), HF + metformin (144 mg/kg in diet; n = 20) or SC + metformin (144 mg/kg in diet; n = 16) diet for 10 weeks before retesting. Body weight and plasma glucose, insulin and leptin were measured. Protein lysates from various brain areas were analysed for alterations in intracellular signalling or production of synaptic proteins.
RESULTS: HF-fed animals developed insulin resistance and an impairment in switching task contingency from matching to non-matching paradigm. Metformin attenuated the insulin resistance and weight gain associated with HF feeding, but had no effect on performance in either MTP or NMTP tasks. No major alteration in proteins associated with insulin signalling or synaptic function was detected in response to HF diet in the hypothalamus, hippocampus, striatum or cortex. CONCLUSIONS/
INTERPRETATION: Metformin prevented the metabolic but not cognitive alterations associated with HF feeding. The HF diet protocol did not change basal insulin signalling in the brain, suggesting that the brain did not develop insulin resistance. These findings indicate that HF diet has deleterious effects on neuronal function over and above those related to insulin resistance and suggest that weight loss may not be sufficient to reverse some damaging effects of poor diet.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22898768     DOI: 10.1007/s00125-012-2686-y

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  47 in total

Review 1.  Insulin resistance, inflammation, and cognition in Alzheimer's Disease: lessons for multiple sclerosis.

Authors:  G Stennis Watson; Suzanne Craft
Journal:  J Neurol Sci       Date:  2006-04-24       Impact factor: 3.181

2.  Improving metabolic control leads to better working memory in adults with type 2 diabetes.

Authors:  Christopher M Ryan; Martin I Freed; Julie A Rood; Alexander R Cobitz; Brian R Waterhouse; Mark W J Strachan
Journal:  Diabetes Care       Date:  2006-02       Impact factor: 19.112

3.  Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling.

Authors:  Eva Kickstein; Sybille Krauss; Paul Thornhill; Désirée Rutschow; Raphael Zeller; John Sharkey; Ritchie Williamson; Melanie Fuchs; Andrea Köhler; Hartmut Glossmann; Rainer Schneider; Calum Sutherland; Susann Schweiger
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

4.  Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study.

Authors:  Rachel A Whitmer; Erica P Gunderson; Elizabeth Barrett-Connor; Charles P Quesenberry; Kristine Yaffe
Journal:  BMJ       Date:  2005-04-29

5.  Advanced glycation end product level, diabetes, and accelerated cognitive aging.

Authors:  Kristine Yaffe; K Lindquist; A V Schwartz; C Vitartas; E Vittinghoff; S Satterfield; E M Simonsick; L Launer; C Rosano; J A Cauley; T Harris
Journal:  Neurology       Date:  2011-09-07       Impact factor: 9.910

Review 6.  Insulin and its evolving partnership with leptin in the hypothalamic control of energy homeostasis.

Authors:  Kevin D Niswender; Denis G Baskin; Michael W Schwartz
Journal:  Trends Endocrinol Metab       Date:  2004-10       Impact factor: 12.015

Review 7.  Adipocytokines and the metabolic complications of obesity.

Authors:  Neda Rasouli; Philip A Kern
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

8.  Determination of metformin in human plasma using hydrophilic interaction liquid chromatography-tandem mass spectrometry.

Authors:  Ang Liu; Stuart P Coleman
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-09-17       Impact factor: 3.205

9.  Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function.

Authors:  Zoe Arvanitakis; Robert S Wilson; Julia L Bienias; Denis A Evans; David A Bennett
Journal:  Arch Neurol       Date:  2004-05

Review 10.  Neurodegenerative disorders associated with diabetes mellitus.

Authors:  Michael Ristow
Journal:  J Mol Med (Berl)       Date:  2004-06-03       Impact factor: 4.599

View more
  32 in total

1.  Prolonged metformin treatment leads to reduced transcription of Nrf2 and neurotrophic factors without cognitive impairment in older C57BL/6J mice.

Authors:  Joanne S Allard; Evelyn J Perez; Koji Fukui; Priscilla Carpenter; Donald K Ingram; Rafael de Cabo
Journal:  Behav Brain Res       Date:  2015-12-14       Impact factor: 3.332

Review 2.  Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress.

Authors:  Mohammed Akbar; Musthafa Mohamed Essa; Ghazi Daradkeh; Mohamed A Abdelmegeed; Youngshim Choi; Lubna Mahmood; Byoung-Joon Song
Journal:  Brain Res       Date:  2016-02-13       Impact factor: 3.252

3.  Dietary high-fat lard intake induces thyroid dysfunction and abnormal morphology in rats.

Authors:  Shan-shan Shao; Yuan-fei Zhao; Yong-feng Song; Chao Xu; Jian-mei Yang; Shi-meng Xuan; Hui-li Yan; Chun-xiao Yu; Meng Zhao; Jin Xu; Jia-jun Zhao
Journal:  Acta Pharmacol Sin       Date:  2014-09-29       Impact factor: 6.150

4.  Metformin: good or bad for the brain?

Authors:  Ilker Tasci
Journal:  Ann Transl Med       Date:  2014-06

5.  Metformin in the diabetic brain: friend or foe?

Authors:  Paula I Moreira
Journal:  Ann Transl Med       Date:  2014-06

Review 6.  Hippocampal insulin resistance and cognitive dysfunction.

Authors:  Geert Jan Biessels; Lawrence P Reagan
Journal:  Nat Rev Neurosci       Date:  2015-10-14       Impact factor: 34.870

7.  Metformin and Sulfonylurea Use and Risk of Incident Dementia.

Authors:  Jeffrey F Scherrer; Joanne Salas; James S Floyd; Susan A Farr; John E Morley; Sascha Dublin
Journal:  Mayo Clin Proc       Date:  2019-08       Impact factor: 7.616

Review 8.  Obesity as a risk factor for Alzheimer's disease: the role of adipocytokines.

Authors:  Liliana Letra; Isabel Santana; Raquel Seiça
Journal:  Metab Brain Dis       Date:  2014-02-20       Impact factor: 3.584

9.  Stop signs in hippocampal insulin signaling: the role of insulin resistance in structural, functional and behavioral deficits.

Authors:  Jim R Fadel; Lawrence P Reagan
Journal:  Curr Opin Behav Sci       Date:  2015-12-01

Review 10.  Damaging effects of a high-fat diet to the brain and cognition: a review of proposed mechanisms.

Authors:  Linnea R Freeman; Vivian Haley-Zitlin; Dorothea S Rosenberger; Ann-Charlotte Granholm
Journal:  Nutr Neurosci       Date:  2013-11-26       Impact factor: 4.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.